Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.
CI Financial Announces Filing and Mailing of Circular for Special Meeting to Approve Plan of Arrangement with Mubadala Capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback